Koronis Pharmaceuticals, Inc. Announces Appointment Of Prominent HIV Researcher Courtney Fletcher, Pharm. D., To Scientific Advisory Board And Jeff Parkins As VP, Clinical Development
9/30/2008 9:24:06 AM
SEATTLE--(BUSINESS WIRE)--Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company’s Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development.
comments powered by